tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

BIOR Stock Latest News

Biora Therapeutics Faces Nasdaq Delisting Challenges
Company AnnouncementsBiora Therapeutics Faces Nasdaq Delisting Challenges
1M ago
8K
BIOR
Biora Therapeutics Reports Q3 2024 Results and Updates
PremiumCompany Announcements
Biora Therapeutics Reports Q3 2024 Results and Updates
1M ago
BIOR
Biora Therapeutics reports Q3 EPS ($5.04) vs (35c) last year
PremiumThe Fly
Biora Therapeutics reports Q3 EPS ($5.04) vs (35c) last year
1M ago
BIOR
BIOR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
BIOR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
BIOR
Biora to sell 745,342 shares at $4.025 in registered direct offering
PremiumThe Fly
Biora to sell 745,342 shares at $4.025 in registered direct offering
2M ago
BIOR
Biora shares progress on its development of BioJet Oral Delivery Platform
PremiumThe FlyBiora shares progress on its development of BioJet Oral Delivery Platform
2M ago
BIOR
Biora Therapeutics trading halted, news pending
Premium
The Fly
Biora Therapeutics trading halted, news pending
2M ago
BIOR
Biora Therapeutics to reveal 00-size BioJet device at PODD meeting
Premium
The Fly
Biora Therapeutics to reveal 00-size BioJet device at PODD meeting
2M ago
BIOR
Biora Therapeutics achieves ISO 13485 certification
PremiumThe Fly
Biora Therapeutics achieves ISO 13485 certification
3M ago
BIOR
Biora Therapeutics granted extension to regain compliance with Nasdaq
PremiumThe Fly
Biora Therapeutics granted extension to regain compliance with Nasdaq
4M ago
BIOR
Biora Therapeutics reports Q2 EPS (4c), consensus (45c)
PremiumThe Fly
Biora Therapeutics reports Q2 EPS (4c), consensus (45c)
4M ago
BIOR
Biora Therapeutics Restructures Debt and Issues New Securities
PremiumCompany Announcements
Biora Therapeutics Restructures Debt and Issues New Securities
4M ago
8K
BIOR
Is BIOR a Buy, Before Earnings?
PremiumPre-EarningsIs BIOR a Buy, Before Earnings?
4M ago
BIOR
Biora Therapeutics Advances Ulcerative Colitis Treatment with BT-600 Trial Success
Premium
Company Announcements
Biora Therapeutics Advances Ulcerative Colitis Treatment with BT-600 Trial Success
5M ago
8K
BIOR
Biora Therapeutics announces data from Phase 1 trial of BT-600
Premium
The Fly
Biora Therapeutics announces data from Phase 1 trial of BT-600
5M ago
BIOR
Biora Therapeutics Reports Promising BT-600 Trial Results
PremiumCompany Announcements
Biora Therapeutics Reports Promising BT-600 Trial Results
6M ago
8K
BIOR
Biora Therapeutics announces clinical trial results for BT-600
PremiumThe Fly
Biora Therapeutics announces clinical trial results for BT-600
6M ago
BIOR
Biora Therapeutics files to sell 2.23M shares of common stock for holders
PremiumThe Fly
Biora Therapeutics files to sell 2.23M shares of common stock for holders
7M ago
BIOR
Biora Therapeutics files $200M mixed securities shelf
PremiumThe Fly
Biora Therapeutics files $200M mixed securities shelf
7M ago
BIOR
Biora Therapeutics presents data on device function of NaviCap Platform
PremiumThe FlyBiora Therapeutics presents data on device function of NaviCap Platform
7M ago
BIOR
Biora Therapeutics Inc. (BIOR) Q1 Earnings Cheat Sheet
Premium
Pre-Earnings
Biora Therapeutics Inc. (BIOR) Q1 Earnings Cheat Sheet
7M ago
BIOR
Biora Therapeutics announces completion of MAD cohorts for BT-600 trial
Premium
The Fly
Biora Therapeutics announces completion of MAD cohorts for BT-600 trial
8M ago
BIOR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >